[- - 2018 free-cashflow reached a new high ZHANGZHOU, China, March 26, 2019 – China Zenix Auto International Limited Financial Highlights Fourth Quarter 2018: ● Revenue was RMB695.4 million (US$101.1 million), down 5.6% year-over-year from RMB736.3 million in the fourth quarter of 2017; ● Sales to th]
[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0% Him]
[- - 2018 free-cashflow reached a new high ZHANGZHOU, China, March 26, 2019 – China Zenix Auto International Limited Financial Highlights Fourth Quarter 2018: ● Revenue was RMB695.4 million (US$101.1 million), down 5.6% year-over-year from RMB736.3 million in the fourth quarter of 2017; ● Sales to th]
[CHINA AUTOMOTIVE SYSTEMS, INC. FORM 10-K INDEX Page PART I 4 Item 1. Business. 4] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-126959) of China Automotive Systems, Inc. of our report da]
[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 40 Item 4A. Unresolved Staff Comments 65 Item 5. Operating and Financial Review and Prospects 65 Item]
[CHINA AUTOMOTIVE SYSTEMS, INC. FORM 10-K INDEX Page PART I 4 Item 1. Business. 4] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-126959) of China Automotive Systems, Inc. of our report da]
[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 40 Item 4A. Unresolved Staff Comments 65 Item 5. Operating and Financial Review and Prospects 65 Item]
[This Form 6-K consists of: 1. 2. 3. 4. Document 1 CONTENTS 2 Company Profile 3 Principal Financial Data and Indicators 6 Changes in Share Capital and Shareholdings of Principal Shareholders 8 Chairman’s Address 11 Business Review and Prospects 19 Management’s Discussion and Analysis 31 Significant E]
[This Form 6-K consists of: 1. 2. 3. 4. Document 1 CONTENTS 2 Company Profile 3 Principal Financial Data and Indicators 6 Changes in Share Capital and Shareholdings of Principal Shareholders 8 Chairman’s Address 11 Business Review and Prospects 19 Management’s Discussion and Analysis 31 Significant E]
[] [December 5, 2018 Dear Ms. Heung Mei Tsui On behalf of the Board of Directions and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc as a director. The compensation is $16,000 per year. I look forward to working with you. Your appointment date is December]
